CIK 0001400118 · <br>Emerging growth company
Sagimet Biosciences Inc.
Sign in to watch- Ticker
- SGMT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 205991472
- Phone
- (650) 561-8600
- Business address
- 950 TOWER LANE, STE 1500, FOSTER CITY, CA, 94404
- Former names
- 3-V Biosciences, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-01-29 | KERINS PATRICK J 10% owner | Other acquisition | +13,139 | 13,139 | ||
| 2024-01-29 | BASKETT FOREST 10% owner | Other disposition | −850,000 | 3,000,275 | ||
| 2024-01-29 | BASKETT FOREST 10% owner | Other acquisition | +260,950 | 260,950 | ||
| 2024-01-29 | BASKETT FOREST 10% owner | Other disposition | −260,950 | 0 | ||
| 2024-01-29 | BASKETT FOREST 10% owner | Other acquisition | +11,300 | 11,300 | ||
| 2024-01-29 | NEA Partners 13, Limited Partnership 10% owner | Other disposition | −850,000 | 3,000,275 | ||
| 2024-01-29 | NEA Partners 13, Limited Partnership 10% owner | Other acquisition | +260,950 | 260,950 | ||
| 2024-01-29 | NEA Partners 13, Limited Partnership 10% owner | Other disposition | −260,950 | 0 | ||
| 2024-01-29 | NEW ENTERPRISE ASSOCIATES 13 LP 10% owner | Other disposition | −850,000 | 3,000,275 | ||
| 2023-12-07 | Happel David President & CEO | Purchase | +1,600 | $4.10 | $7K | 627,100 |
| 2023-11-17 | Rozek Elizabeth General Counsel and CCO | Grant or award | +171,420 | 171,420 | ||
| 2023-11-17 | Martins Eduardo Bruno Chief Medical Officer | Grant or award | +89,570 | 89,570 | ||
| 2023-11-17 | Kemble George Executive Chairman | Grant or award | +150,750 | 156,380 | ||
| 2023-11-17 | Happel David President & CEO | Grant or award | +624,910 | 625,500 | ||
| 2023-11-16 | Happel David President & CEO | Purchase | +590 | $2.35 | $1K | 590 |
| 2023-09-07 | Kemble George Executive Chairman | Option exercise | +5,630 | $0.79 | $4K | 5,630 |
| 2023-09-07 | Kemble George Executive Chairman | Option exercise · Stock Option (Right to Buy) | −5,630 | 0 | ||
| 2023-07-18 | NEW ENTERPRISE ASSOCIATES 13 LP 10% owner | Other disposition | −37,676 | 0 | ||
| 2023-07-18 | NEW ENTERPRISE ASSOCIATES 13 LP 10% owner | Other acquisition | +37,676 | 37,676 | ||
| 2023-07-18 | NEW ENTERPRISE ASSOCIATES 13 LP 10% owner | Conversion | +3,769,857 | 3,807,533 |
Page 5 of 10 · 194 trades